Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-19-057685

Director sold 42,000 shares at $67.41 ($2,831,388)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bolzon Bradley J PhD Director 2019-11-19 Sale −13,745 $67.41 $926,605 0 D
Bolzon Bradley J PhD Director 2019-11-19 Sale −28,255 $67.41 $1,904,783 596,741 I
Open-market sales · 42,000 sh · avg $67.41 · $2,831,388
Loading xslF345X03/doc4.xml…